Vapotherm Executives

VAPODelisted Stock  USD 0.40  0.00  0.00%   
Vapotherm employs about 261 people. The company is managed by 19 executives with a total tenure of roughly 77 years, averaging almost 4.0 years of service per executive, having 13.74 employees per reported executive. Analysis of Vapotherm's management performance can provide insight into the firm performance.
Joseph Army  CEO
President, Chief Executive Officer, Director
James Liken  Chairman
Independent Chairman of the Board
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Vapotherm's latest congressional trading

Congressional trading in companies like Vapotherm, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Vapotherm by those in governmental positions are based on the same information available to the general public.
2024-10-30Senator Richard BlumenthalAcquired Under $15KVerify

Vapotherm Management Team Effectiveness

The company has return on total asset (ROA) of (0.3139) % which means that it has lost $0.3139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.8669) %, meaning that it created substantial loss on money invested by shareholders. Vapotherm's management efficiency ratios could be used to measure how well Vapotherm manages its routine affairs as well as how well it operates its assets and liabilities.

Vapotherm Workforce Comparison

Vapotherm is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,267. Vapotherm totals roughly 261 in number of employees claiming about 21% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.63.

Vapotherm Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vapotherm insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vapotherm's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Vapotherm insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vapotherm Notable Stakeholders

A Vapotherm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vapotherm often face trade-offs trying to please all of them. Vapotherm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vapotherm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joseph ArmyPresident, Chief Executive Officer, DirectorProfile
James LikenIndependent Chairman of the BoardProfile
John LandryChief Financial Officer, Senior Vice President, Principal Accounting Officer, TreasurerProfile
Gregoire RamadeSenior Vice President, Chief Commercial OfficerProfile
Brian LawrenceSenior Vice President, Chief Technology OfficerProfile
Lindsay BeckerVice President of Human ResourcesProfile
Anthony ArnerichIndependent DirectorProfile
Donald SpenceIndependent DirectorProfile
CPA CPAPres CEOProfile
Elizabeth WeathermanIndependent DirectorProfile
Lance BerryIndependent DirectorProfile
James LightmanGen VPProfile
Lori KnowlesDirectorProfile
Dorota MckayChief Accounting Officer, ControllerProfile
Marina HahnIndependent DirectorProfile
William NilandFounderProfile
Mary MoynihanDirectorProfile
Anthony HaagenVP ComplianceProfile
FAAP MDVP OfficerProfile

About Vapotherm Management Performance

The success or failure of an entity such as Vapotherm often depends on how effective the management is. Vapotherm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vapotherm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vapotherm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Vapotherm operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 510 people.
The data published in Vapotherm's official financial statements typically reflect Vapotherm's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Vapotherm's quantitative information. For example, before you start analyzing numbers published by Vapotherm accountants, it's essential to understand Vapotherm's liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.

Vapotherm Workforce Analysis

Traditionally, organizations such as Vapotherm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vapotherm within its industry.

Vapotherm Manpower Efficiency

Return on Vapotherm Manpower

Revenue Per Employee255.9K
Revenue Per Executive3.5M
Net Loss Per Employee433.9K
Net Loss Per Executive6M
Working Capital Per Employee154.5K
Working Capital Per Executive2.1M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in Vapotherm OTC Stock

If you are still planning to invest in Vapotherm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vapotherm's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins